COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Roland Derwand, Martin Scholz, Vladimir Zelenko
International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106214
The aim of this study was to describe the outcomes of patients with coronavirus disease 2019 in the outpatient setting after early treatment with zinc, low-dose hydroxychloroquine and azithromycin (triple therapy) dependent on risk stratification. This was a retrospective case series study in the general practice setting. A total of 141 COVID-19 patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the year 2020 were included. The main outcome measures were risk-stratified treatment decision and rates of hospitalisation and all-cause death. A median of 4 days [interquartile range (IQR) 3-6 days; available for n = 66/141 patients] after the onset of symptoms, 141 patients (median age 58 years, IQR 40-67 years; 73.0% male) received a prescription for triple therapy for 5 days. Independent public reference data from 377 confirmed COVID-19 patients in the same community were used as untreated controls. Of 141 treated patients, 4 (2.8%) were hospitalised, which was significantly fewer ( P < 0.001) compared with 58 (15.4%) of 377 untreated patients [odds ratio (OR) = 0.16, 95% confidence interval (CI) 0.06-0.5]. One patient (0.7%) in the treatment group died versus 13 patients (3.4%) in the untreated group (OR = 0.2, 95% CI 0.03-1.5; P = 0.12). No cardiac side effects were observed. Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset using triple therapy, including the combination of zinc with low-dose hydroxychloroquine, was associated with significantly fewer hospitalisations.
Competing interests RD is/was at the time of writing an employee of Alexion Pharma Germany GmbH, and his engagement and contribution to this study and publication was private and independent from his employer; MS is/was at the time of writing External Senior Advisor for the company LEUKOCARE (Munich, Germany) and is/was Manging Director at Starts-and -Ups Consulting (Frankfurt, Germany); VZ is/was a general practitioner in New York State (USA).
Ethical approval This study was approved by the Western Institutional Review Board and was exempt under 45 CFR § 46.104(d)(4). Ref. Number: D4-Excemption-Zelenko (06-16-2020).
References
Anderson, Roussel, Zouari, Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus, J Am Coll Nutr,
doi:10.1080/07315724.2001.10719034
Andreani, Bideau, Duflot, In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect, Microb Pathog,
doi:10.1016/j.micpath.2020.104228
Atri, Siddiqi, Lang, COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies, JACC Basic Transl Sci,
doi:10.1016/j.jacbts.2020.04.002
Boulware, Pullen, Bangdiwala, A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19, N Engl J Med,
doi:10.1056/NEJMoa2016638
Braun, Rosenfeldt, Pharmaco-nutrient interactions-a systematic review of zinc and antihypertensive therapy, Int J Clin Pract,
doi:10.1111/ijcp.12040
Carlucci, Ahuja, Petrilli, Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients, medRxiv,
doi:10.1101/2020.05.02.20080036
Chen, Wu, Chen, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ,
doi:10.1136/bmj.m1091
Coutard, Valle, De Lamballerie, The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade, Antiviral Res,
doi:10.1016/j.antiviral.2020.104742
Derwand, Scholz, Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?, Med Hypotheses,
doi:10.1016/j.mehy.2020.109815
Ervin, Kennedy-Stephenson, Mineral intakes of elderly adult supplement and non-supplement users in the third National Health and Nutrition Examination Survey, J Nutr,
doi:10.1093/jn/132.11.3422
Esper, Da Silva, Oikawa, Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine
Fry, Goswami, Nahar, Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial, Lancet Infect Dis,
doi:10.1016/s1473-3099(13)70267-6
Gautret, Lagier, Parola, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents,
doi:10.1016/j.ijantimicag.2020.105949
Geleris, Sun, Platt, Observational study of hydroxychloroquine in hospitalized patients with COVID-19, N Engl J Med,
doi:10.1056/NEJMoa2012410
Ghaly, Knezevic, What happened to 'patient first' and 'do no harm' medical principles?, Surg Neurol Int,
doi:10.4103/sni.sni_447_17
Giacomelli, Pezzati, Conti, Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study, Clin Infect Dis,
doi:10.1093/cid/ciaa330
Gordon, Amissah-Arthur, Gayed, The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults, Rheumatology,
doi:10.1093/rheumatology/kex286
Gupta, Real-world clinical effectiveness and tolerability of hydroxychloroquine 400 mg in uncontrolled type 2 diabetes subjects who are not willing to initiate insulin therapy (HYQ-Real-World Study), Curr Diabetes Rev,
doi:10.2174/1573399815666190425182008
Johnson, Rigge, Culliford, Primary care risk stratification in COPD using routinely collected data: a secondary data analysis, NPJ Prim Care Respir Med,
doi:10.1038/s41533-019-0154-6
Kane, Hydroxychloroquine sulfate. Drug usage statistics
Lane, Weaver, Kostka, Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study, medRxiv,
doi:10.1101/2020.04.08.20054551
Liu, Cao, Xu, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov,
doi:10.1038/s41421-020-0156-0
Lovato, De Filippis, Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms, Ear Nose Throat J,
doi:10.1177/0145561320920762
Mahevas, Tran, Roumier, No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial, medRxiv,
doi:10.1101/2020.04.10.20060699
Mehra, Ruschitzka, Patel, Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet,
doi:10.1016/S0140-6736(20)31324-6
Mercer, Rekedal, Garg, Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals, Arthritis Res Ther,
doi:10.1186/ar3868
Millet, Whittaker, Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein, Proc Natl Acad Sci U S A,
doi:10.1073/pnas.1407087111
Million, Gautret, Colson, Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world, New Microbes New Infect,
doi:10.1016/j.nmni.2020.100709
Million, Lagier, Gautret, Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France, Travel Med Infect Dis,
doi:10.1016/j.tmaid.2020.101738
Onder, Rezza, Brusaferro, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA,
doi:10.1001/jama.2020.4683
Pareek, Chandurkar, Thomas, Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone, Curr Med Res Opin,
doi:10.1185/03007995.2014.909393
Prasad, Beck, Bao, Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress, Am J Clin Nutr,
doi:10.1093/ajcn/85.3.837
Richardson, Hirsch, Narasimhan, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA,
doi:10.1001/jama.2020.6775
Risch, Early outpatient treatment of symptomatic, high-risk COVID-19 patients that should be ramped-up immediately as key to the pandemic crisis, Am J Epidemiol,
doi:10.1093/aje/kwaa093
Shiryaev, Remacle, Ratnikov, Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens, J Biol Chem,
doi:10.1074/jbc.M703847200
Siddiqi, Mehra, COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal, J Heart Lung Transplant,
doi:10.1016/j.healun.2020.03.012
Siemieniuk, Bartoszko, Ge, Drug treatments for COVID-19: living systematic review and network meta-analysis, BMJ,
doi:10.1136/bmj.m2980
Stawowy, Kallisch, Pereira Stawowy, Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis, Virchows Arch,
doi:10.1007/s00428-004-1198-7
Tang, Cao, Han, Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial, medRxiv,
doi:10.1101/2020.04.10.20060558
Van Den Akker, Buntinx, Metsemakers, Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases, J Clin Epidemiol,
doi:10.1016/s0895-4356(97)00306-5
Velthuis, Van Den Worm, Sims, Zn 2 + inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture, PLoS Pathog,
doi:10.1371/journal.ppat.1001176
Wallace, The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review, Lupus
Wang, Hu, Hu, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA,
doi:10.1001/jama.2020.1585
Yang, Shen, Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19, Int J Biol Sci,
doi:10.7150/ijbs.45498
Yao, Ye, Zhang, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis,
doi:10.1093/cid/ciaa237
Yu, Li, Chen, Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19, Sci China Life Sci,
doi:10.1007/s11427-020-1732-2
Zarychanski, Stuart, Kumar, Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection, CMAJ,
doi:10.1503/cmaj.091884
Zou, Ruan, Huang, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N Engl J Med,
doi:10.1056/NEJMc2001737
{ 'indexed': {'date-parts': [[2024, 3, 1]], 'date-time': '2024-03-01T07:06:16Z', 'timestamp': 1709276776168},
'reference-count': 69,
'publisher': 'Elsevier BV',
'issue': '6',
'license': [ { 'start': { 'date-parts': [[2020, 12, 1]],
'date-time': '2020-12-01T00:00:00Z',
'timestamp': 1606780800000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'},
{ 'start': { 'date-parts': [[2020, 10, 25]],
'date-time': '2020-10-25T00:00:00Z',
'timestamp': 1603584000000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}],
'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au',
'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'],
'crossmark-restriction': True},
'published-print': {'date-parts': [[2020, 12]]},
'DOI': '10.1016/j.ijantimicag.2020.106214',
'type': 'journal-article',
'created': { 'date-parts': [[2020, 10, 26]],
'date-time': '2020-10-26T16:42:42Z',
'timestamp': 1603730562000},
'page': '106214',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 79,
'title': 'COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine '
'and azithromycin: a retrospective case series study',
'prefix': '10.1016',
'volume': '56',
'author': [ {'given': 'Roland', 'family': 'Derwand', 'sequence': 'first', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-7009-9988',
'authenticated-orcid': False,
'given': 'Martin',
'family': 'Scholz',
'sequence': 'additional',
'affiliation': []},
{'given': 'Vladimir', 'family': 'Zelenko', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'reference': [ { 'key': '10.1016/j.ijantimicag.2020.106214_bib0001',
'doi-asserted-by': 'crossref',
'first-page': '44',
'DOI': '10.1016/j.ijid.2020.03.004',
'article-title': 'The SARS-CoV-2 outbreak: what we know',
'volume': '94',
'author': 'Wu',
'year': '2020',
'journal-title': 'Int J Infect Dis'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0002',
'doi-asserted-by': 'crossref',
'first-page': '518',
'DOI': '10.1016/j.jacbts.2020.04.002',
'article-title': 'COVID-19 for the cardiologist: a current review of the virology, '
'clinical epidemiology, cardiac and other clinical manifestations and '
'potential therapeutic strategies',
'volume': '5',
'author': 'Atri',
'year': '2020',
'journal-title': 'JACC Basic Transl Sci'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0003',
'article-title': 'Hospitalization and 30-day fatality in 121,263 COVID-19 outpatient '
'cases',
'volume': '8',
'author': 'Prieto-Alhambra',
'year': '2020',
'journal-title': 'medRxiv'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0004',
'doi-asserted-by': 'crossref',
'first-page': '856',
'DOI': '10.1016/S0196-0644(89)80213-6',
'article-title': 'Analysis of emergency department management of suspected bacterial '
'meningitis',
'volume': '18',
'author': 'Talan',
'year': '1989',
'journal-title': 'Ann Emerg Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0005',
'article-title': 'Timing of antiviral treatment initiation is critical to reduce '
'SARS-CoV-2 viral load',
'author': 'Gonçalves',
'year': '2020',
'journal-title': 'medRxiv'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0006',
'doi-asserted-by': 'crossref',
'first-page': '405',
'DOI': '10.1016/j.healun.2020.03.012',
'article-title': 'COVID-19 illness in native and immunosuppressed states: a '
'clinical-therapeutic staging proposal',
'volume': '39',
'author': 'Siddiqi',
'year': '2020',
'journal-title': 'J Heart Lung Transplant'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0007',
'doi-asserted-by': 'crossref',
'first-page': '109',
'DOI': '10.1016/S1473-3099(13)70267-6',
'article-title': 'Efficacy of oseltamivir treatment started within 5 days of symptom '
'onset to reduce influenza illness duration and virus shedding in an '
'urban setting in Bangladesh: a randomised placebo-controlled trial',
'volume': '14',
'author': 'Fry',
'year': '2014',
'journal-title': 'Lancet Infect Dis'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0008',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.tmaid.2020.101658',
'article-title': 'Repurposing antimalarials and other drugs for COVID-19',
'volume': '34',
'author': 'Schlagenhauf',
'year': '2020',
'journal-title': 'Travel Med Infect Dis'},
{ 'issue': 'Suppl 1',
'key': '10.1016/j.ijantimicag.2020.106214_bib0009',
'doi-asserted-by': 'crossref',
'first-page': 'S59',
'DOI': '10.1177/0961203396005001131',
'article-title': 'The use of chloroquine and hydroxychloroquine for non-infectious '
'conditions other than rheumatoid arthritis or lupus: a critical review',
'volume': '5',
'author': 'Wallace',
'year': '1996',
'journal-title': 'Lupus'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0010',
'doi-asserted-by': 'crossref',
'first-page': 'e1',
'DOI': '10.1093/rheumatology/kex286',
'article-title': 'The British Society for Rheumatology guideline for the management of '
'systemic lupus erythematosus in adults',
'volume': '57',
'author': 'Gordon',
'year': '2018',
'journal-title': 'Rheumatology (Oxford)'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0011',
'series-title': 'Model list of essential medicines',
'year': '2020'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0012',
'unstructured': 'Kane S.P.Hydroxychloroquine sulfate. Drug usage statistics, United '
'States, 2007–2017. ClinCalc DrugStats Database, Version '
'20.1.https://clincalc.com/DrugStats/Drugs/HydroxychloroquineSulfate '
'[accessed 23 May 2020].'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0013',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.ijantimicag.2020.105949',
'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results '
'of an open-label non-randomized clinical trial',
'volume': '56',
'author': 'Gautret',
'year': '2020',
'journal-title': 'Int J Antimicrob Agents'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0014',
'article-title': 'Hydroxychloroquine in patients mainly with mild to moderate COVID-19: '
'an open-label, randomized, controlled trial',
'author': 'Tang',
'year': '2020',
'journal-title': 'medRxiv'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0015',
'first-page': '215',
'article-title': 'A pilot study of hydroxychloroquine in treatment of patients with '
'moderate COVID-19',
'volume': '49',
'author': 'Chen',
'year': '2020',
'journal-title': 'Zhejiang Da Xue Xue Bao Yi Xue Ban'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0016',
'article-title': 'No evidence of clinical efficacy of hydroxychloroquine in patients '
'hospitalized for COVID-19 infection with oxygen requirement: results of '
'a study using routinely collected data to emulate a target trial',
'author': 'Mahevas',
'year': '2020',
'journal-title': 'medRxiv'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0017',
'doi-asserted-by': 'crossref',
'first-page': '1820',
'DOI': '10.1016/S0140-6736(20)31324-6',
'article-title': 'Retraction—Hydroxychloroquine or chloroquine with or without a '
'macrolide for treatment of COVID-19: a multinational registry analysis',
'volume': '395',
'author': 'Mehra',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0018',
'doi-asserted-by': 'crossref',
'first-page': 'E102',
'DOI': '10.1016/S0140-6736(20)31290-3',
'article-title': 'Expression of concern: Hydroxychloroquine or chloroquine with or '
'without a macrolide for treatment of COVID-19: a multinational registry '
'analysis',
'volume': '395',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0019',
'doi-asserted-by': 'crossref',
'first-page': '1724',
'DOI': '10.7150/ijbs.45498',
'article-title': 'Targeting the endocytic pathway and autophagy process as a novel '
'therapeutic strategy in COVID-19',
'volume': '16',
'author': 'Yang',
'year': '2020',
'journal-title': 'Int J Biol Sci'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0020',
'doi-asserted-by': 'crossref',
'DOI': '10.1371/journal.pone.0109180',
'article-title': 'Chloroquine is a zinc ionophore',
'volume': '9',
'author': 'Xue',
'year': '2014',
'journal-title': 'PLoS One'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0021',
'doi-asserted-by': 'crossref',
'DOI': '10.1371/journal.ppat.1001176',
'article-title': 'Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in '
'vitro and zinc ionophores block the replication of these viruses in '
'cell culture',
'volume': '6',
'author': 'te Velthuis',
'year': '2010',
'journal-title': 'PLoS Pathog'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0022',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.mehy.2020.109815',
'article-title': 'Does zinc supplementation enhance the clinical efficacy of '
"chloroquine/hydroxychloroquine to win today's battle against COVID-19?",
'volume': '142',
'author': 'Derwand',
'year': '2020',
'journal-title': 'Med Hypotheses'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0023',
'article-title': 'Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and '
'azithromycin alone: outcomes in hospitalized COVID-19 patients',
'author': 'Carlucci',
'year': '2020',
'journal-title': 'medRxiv'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0024',
'doi-asserted-by': 'crossref',
'first-page': 'm2980',
'DOI': '10.1136/bmj.m2980',
'article-title': 'Drug treatments for COVID-19: living systematic review and network '
'meta-analysis',
'volume': '370',
'author': 'Siemieniuk',
'year': '2020',
'journal-title': 'BMJ'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0025',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.nmni.2020.100709',
'article-title': 'Clinical efficacy of chloroquine derivatives in COVID-19 infection: '
'comparative meta-analysis between the big data and the real world',
'volume': '38',
'author': 'Million',
'year': '2020',
'journal-title': 'New Microbes New Infect'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0026',
'doi-asserted-by': 'crossref',
'first-page': '517',
'DOI': '10.1056/NEJMoa2016638',
'article-title': 'A randomized trial of hydroxychloroquine as postexposure prophylaxis '
'for COVID-19',
'volume': '383',
'author': 'Boulware',
'year': '2020',
'journal-title': 'N Engl J Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0027',
'doi-asserted-by': 'crossref',
'first-page': '411',
'DOI': '10.1016/S1473-3099(20)30113-4',
'article-title': 'Viral load of SARS-CoV-2 in clinical samples',
'volume': '20',
'author': 'Pan',
'year': '2020',
'journal-title': 'Lancet Infect Dis'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0028',
'doi-asserted-by': 'crossref',
'first-page': 'e86',
'DOI': '10.3346/jkms.2020.35.e86',
'article-title': 'Viral load kinetics of SARS-CoV-2 infection in first two patients in '
'Korea',
'volume': '35',
'author': 'Kim',
'year': '2020',
'journal-title': 'J Korean Med Sci'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0029',
'doi-asserted-by': 'crossref',
'first-page': '1177',
'DOI': '10.1056/NEJMc2001737',
'article-title': 'SARS-CoV-2 viral load in upper respiratory specimens of infected '
'patients',
'volume': '382',
'author': 'Zou',
'year': '2020',
'journal-title': 'N Engl J Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0030',
'doi-asserted-by': 'crossref',
'first-page': '497',
'DOI': '10.1016/S0140-6736(20)30183-5',
'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in '
'Wuhan, China',
'volume': '395',
'author': 'Huang',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0031',
'doi-asserted-by': 'crossref',
'first-page': '1061',
'DOI': '10.1001/jama.2020.1585',
'article-title': 'Clinical characteristics of 138 hospitalized patients with 2019 novel '
'coronavirus-infected pneumonia in Wuhan, China',
'volume': '323',
'author': 'Wang',
'year': '2020',
'journal-title': 'JAMA'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0032',
'doi-asserted-by': 'crossref',
'first-page': '257',
'DOI': '10.1503/cmaj.091884',
'article-title': 'Correlates of severe disease in patients with 2009 pandemic influenza '
'(H1N1) virus infection',
'volume': '182',
'author': 'Zarychanski',
'year': '2010',
'journal-title': 'CMAJ'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0033',
'series-title': 'Influenza (flu). For clinicians: antiviral medication',
'year': '2020'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0034',
'series-title': 'Managing people at high risk for severe varicella',
'year': '2020'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0035',
'series-title': 'Empirical treatment with hydroxychloroquine and azithromycin for '
'suspected cases of COVID-19 followed-up by telemedicine',
'author': 'Esper',
'year': '2020'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0036',
'doi-asserted-by': 'crossref',
'first-page': '42',
'DOI': '10.1038/s41533-019-0154-6',
'article-title': 'Primary care risk stratification in COPD using routinely collected '
'data: a secondary data analysis',
'volume': '29',
'author': 'Johnson',
'year': '2019',
'journal-title': 'NPJ Prim Care Respir Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0037',
'series-title': 'People at increased risk and other people who need to take extra '
'precautions',
'year': '2020'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0038',
'doi-asserted-by': 'crossref',
'first-page': '367',
'DOI': '10.1016/S0895-4356(97)00306-5',
'article-title': 'Multimorbidity in general practice: prevalence, incidence, and '
'determinants of co-occurring chronic and recurrent diseases',
'volume': '51',
'author': 'van den Akker',
'year': '1998',
'journal-title': 'J Clin Epidemiol'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0039',
'first-page': '1775',
'article-title': 'Case-fatality rate and characteristics of patients dying in relation to '
'COVID-19 in Italy',
'volume': '323',
'author': 'Onder',
'year': '2020',
'journal-title': 'JAMA'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0040',
'doi-asserted-by': 'crossref',
'first-page': '176',
'DOI': '10.4103/sni.sni_447_17',
'article-title': 'What happened to ‘patient first’ and ‘do no harm’ medical principles?',
'volume': '9',
'author': 'Ghaly',
'year': '2018',
'journal-title': 'Surg Neurol Int'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0041',
'doi-asserted-by': 'crossref',
'first-page': '16',
'DOI': '10.1038/s41421-020-0156-0',
'article-title': 'Hydroxychloroquine, a less toxic derivative of chloroquine, is '
'effective in inhibiting SARS-CoV-2 infection in vitro',
'volume': '6',
'author': 'Liu',
'year': '2020',
'journal-title': 'Cell Discov'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0042',
'doi-asserted-by': 'crossref',
'first-page': '732',
'DOI': '10.1093/cid/ciaa237',
'article-title': 'In vitro antiviral activity and projection of optimized dosing design '
'of hydroxychloroquine for the treatment of severe acute respiratory '
'syndrome coronavirus 2 (SARS-CoV-2)',
'volume': '71',
'author': 'Yao',
'year': '2020',
'journal-title': 'Clin Infect Dis'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0043',
'first-page': '4539',
'article-title': 'Efficacy of chloroquine and hydroxychloroquine in the treatment of '
'COVID-19',
'volume': '24',
'author': 'Meo',
'year': '2020',
'journal-title': 'Eur Rev Med Pharmacol Sci'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0044',
'doi-asserted-by': 'crossref',
'first-page': '771',
'DOI': '10.1111/j.1365-2125.1989.tb03439.x',
'article-title': 'Bioavailability of hydroxychloroquine tablets in healthy volunteers',
'volume': '27',
'author': 'Tett',
'year': '1989',
'journal-title': 'Br J Clin Pharmacol'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0045',
'doi-asserted-by': 'crossref',
'first-page': '837',
'DOI': '10.1093/ajcn/85.3.837',
'article-title': 'Zinc supplementation decreases incidence of infections in the elderly: '
'effect of zinc on generation of cytokines and oxidative stress',
'volume': '85',
'author': 'Prasad',
'year': '2007',
'journal-title': 'Am J Clin Nutr'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0046',
'doi-asserted-by': 'crossref',
'first-page': '696',
'DOI': '10.1093/advances/nmz013',
'article-title': 'The role of zinc in antiviral immunity',
'volume': '10',
'author': 'Read',
'year': '2019',
'journal-title': 'Adv Nutr'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0047',
'doi-asserted-by': 'crossref',
'first-page': '36219',
'DOI': '10.1074/jbc.M400338200',
'article-title': 'Furin inhibition by compounds of copper and zinc',
'volume': '279',
'author': 'Podsiadlo',
'year': '2004',
'journal-title': 'J Biol Chem'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0048',
'doi-asserted-by': 'crossref',
'first-page': '351',
'DOI': '10.1007/s00428-004-1198-7',
'article-title': 'Immunohistochemical localization of subtilisin/kexin-like proprotein '
'convertases in human atherosclerosis',
'volume': '446',
'author': 'Stawowy',
'year': '2005',
'journal-title': 'Virchows Arch'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0049',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.antiviral.2020.104742',
'article-title': 'The spike glycoprotein of the new coronavirus 2019-nCoV contains a '
'furin-like cleavage site absent in CoV of the same clade',
'volume': '176',
'author': 'Coutard',
'year': '2020',
'journal-title': 'Antiviral Res'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0050',
'doi-asserted-by': 'crossref',
'first-page': '15214',
'DOI': '10.1073/pnas.1407087111',
'article-title': 'Host cell entry of Middle East respiratory syndrome coronavirus after '
'two-step, furin-mediated activation of the spike protein',
'volume': '111',
'author': 'Millet',
'year': '2014',
'journal-title': 'Proc Natl Acad Sci U S A'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0051',
'doi-asserted-by': 'crossref',
'first-page': '20847',
'DOI': '10.1074/jbc.M703847200',
'article-title': 'Targeting host cell furin proprotein convertases as a therapeutic '
'strategy against bacterial toxins and viral pathogens',
'volume': '282',
'author': 'Shiryaev',
'year': '2007',
'journal-title': 'J Biol Chem'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0052',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.micpath.2020.104228',
'article-title': 'In vitro testing of combined hydroxychloroquine and azithromycin on '
'SARS-CoV-2 shows synergistic effect',
'volume': '145',
'author': 'Andreani',
'year': '2020',
'journal-title': 'Microb Pathog'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0053',
'doi-asserted-by': 'crossref',
'first-page': '3422',
'DOI': '10.1093/jn/132.11.3422',
'article-title': 'Mineral intakes of elderly adult supplement and non-supplement users in '
'the third National Health and Nutrition Examination Survey',
'volume': '132',
'author': 'Ervin',
'year': '2002',
'journal-title': 'J Nutr'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0054',
'doi-asserted-by': 'crossref',
'first-page': '212',
'DOI': '10.1080/07315724.2001.10719034',
'article-title': 'Potential antioxidant effects of zinc and chromium supplementation in '
'people with type 2 diabetes mellitus',
'volume': '20',
'author': 'Anderson',
'year': '2001',
'journal-title': 'J Am Coll Nutr'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0055',
'doi-asserted-by': 'crossref',
'first-page': '717',
'DOI': '10.1111/ijcp.12040',
'article-title': 'Pharmaco-nutrient interactions—a systematic review of zinc and '
'antihypertensive therapy',
'volume': '67',
'author': 'Braun',
'year': '2013',
'journal-title': 'Int J Clin Pract'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0056',
'article-title': 'Safety of hydroxychloroquine, alone and in combination with '
'azithromycin, in light of rapid wide-spread use for COVID-19: a '
'multinational, network cohort and self-controlled case series study',
'author': 'Lane',
'year': '2020',
'journal-title': 'medRxiv'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0057',
'doi-asserted-by': 'crossref',
'first-page': '2052',
'DOI': '10.1001/jama.2020.6775',
'article-title': 'Presenting characteristics, comorbidities, and outcomes among 5700 '
'patients hospitalized with COVID-19 in the New York City Area',
'volume': '323',
'author': 'Richardson',
'year': '2020',
'journal-title': 'JAMA'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0058',
'doi-asserted-by': 'crossref',
'first-page': '569',
'DOI': '10.1177/0145561320920762',
'article-title': 'Clinical presentation of COVID-19: a systematic review focusing on '
'upper airway symptoms',
'volume': '99',
'author': 'Lovato',
'year': '2020',
'journal-title': 'Ear Nose Throat J'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0059',
'doi-asserted-by': 'crossref',
'first-page': 'm1091',
'DOI': '10.1136/bmj.m1091',
'article-title': 'Clinical characteristics of 113 deceased patients with coronavirus '
'disease 2019: retrospective study',
'volume': '368',
'author': 'Chen',
'year': '2020',
'journal-title': 'BMJ'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0060',
'doi-asserted-by': 'crossref',
'first-page': '889',
'DOI': '10.1093/cid/ciaa330',
'article-title': 'Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a '
'cross-sectional study',
'volume': '71',
'author': 'Giacomelli',
'year': '2020',
'journal-title': 'Clin Infect Dis'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0061',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.tmaid.2020.101738',
'article-title': 'Early treatment of COVID-19 patients with hydroxychloroquine and '
'azithromycin: a retrospective analysis of 1061 cases in Marseille, '
'France',
'volume': '35',
'author': 'Million',
'year': '2020',
'journal-title': 'Travel Med Infect Dis'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0062',
'doi-asserted-by': 'crossref',
'first-page': '2411',
'DOI': '10.1056/NEJMoa2012410',
'article-title': 'Observational study of hydroxychloroquine in hospitalized patients with '
'COVID-19',
'volume': '382',
'author': 'Geleris',
'year': '2020',
'journal-title': 'N Engl J Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0063',
'doi-asserted-by': 'crossref',
'DOI': '10.1093/aje/kwaa093',
'article-title': 'Early outpatient treatment of symptomatic, high-risk COVID-19 patients '
'that should be ramped-up immediately as key to the pandemic crisis',
'author': 'Risch',
'year': '2020',
'journal-title': 'Am J Epidemiol'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0064',
'doi-asserted-by': 'crossref',
'first-page': '1515',
'DOI': '10.1007/s11427-020-1732-2',
'article-title': 'Low dose of hydroxychloroquine reduces fatality of critically ill '
'patients with COVID-19',
'volume': '63',
'author': 'Yu',
'year': '2020',
'journal-title': 'Sci China Life Sci'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0065',
'doi-asserted-by': 'crossref',
'first-page': 'R135',
'DOI': '10.1186/ar3868',
'article-title': 'Hydroxychloroquine improves insulin sensitivity in obese non-diabetic '
'individuals',
'volume': '14',
'author': 'Mercer',
'year': '2012',
'journal-title': 'Arthritis Res Ther'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0066',
'doi-asserted-by': 'crossref',
'first-page': '1257',
'DOI': '10.1185/03007995.2014.909393',
'article-title': 'Efficacy and safety of hydroxychloroquine in the treatment of type 2 '
'diabetes mellitus: a double blind, randomized comparison with '
'pioglitazone',
'volume': '30',
'author': 'Pareek',
'year': '2014',
'journal-title': 'Curr Med Res Opin'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0067',
'doi-asserted-by': 'crossref',
'first-page': '510',
'DOI': '10.2174/1573399815666190425182008',
'article-title': 'Real-world clinical effectiveness and tolerability of '
'hydroxychloroquine 400 mg in uncontrolled type 2 diabetes subjects who '
'are not willing to initiate insulin therapy (HYQ-Real-World Study)',
'volume': '15',
'author': 'Gupta',
'year': '2019',
'journal-title': 'Curr Diabetes Rev'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0068',
'doi-asserted-by': 'crossref',
'first-page': '738',
'DOI': '10.1016/S2213-2600(20)30229-0',
'article-title': 'Management of acute kidney injury in patients with COVID-19',
'volume': '8',
'author': 'Ronco',
'year': '2020',
'journal-title': 'Lancet Respir Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106214_bib0069',
'series-title': 'Plaquenil drug monograph',
'year': '2017'}],
'container-title': 'International Journal of Antimicrobial Agents',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920304258?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920304258?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2022, 7, 3]],
'date-time': '2022-07-03T15:57:44Z',
'timestamp': 1656863864000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0924857920304258'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 12]]},
'references-count': 69,
'journal-issue': {'issue': '6', 'published-print': {'date-parts': [[2020, 12]]}},
'alternative-id': ['S0924857920304258'],
'URL': 'http://dx.doi.org/10.1016/j.ijantimicag.2020.106214',
'relation': { 'has-preprint': [ { 'id-type': 'doi',
'id': '10.20944/preprints202007.0025.v1',
'asserted-by': 'object'}]},
'ISSN': ['0924-8579'],
'subject': ['Pharmacology (medical)', 'Infectious Diseases', 'Microbiology (medical)', 'General Medicine'],
'container-title-short': 'International Journal of Antimicrobial Agents',
'published': {'date-parts': [[2020, 12]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose '
'hydroxychloroquine and azithromycin: a retrospective case series study',
'name': 'articletitle',
'label': 'Article Title'},
{ 'value': 'International Journal of Antimicrobial Agents',
'name': 'journaltitle',
'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.ijantimicag.2020.106214',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2020 The Author(s). Published by Elsevier Ltd.',
'name': 'copyright',
'label': 'Copyright'}],
'article-number': '106214'}